These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6338768

  • 1. A double-masked comparison of ocular decongestants as therapy for allergic conjunctivitis.
    Lanier BQ, Tremblay N, Smith JP, deFaller JM.
    Ann Allergy; 1983 Mar; 50(3):174-7. PubMed ID: 6338768
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV, Udell IJ.
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [Abstract] [Full Text] [Related]

  • 3. Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial.
    Miller J, Wolf EH.
    Ann Allergy; 1975 Aug; 35(2):81-6. PubMed ID: 1096685
    [Abstract] [Full Text] [Related]

  • 4. Treatment of allergic conjunctivitis with ocular decongestants.
    Smith JP, Lanier BQ, Tremblay N, Ward RL, deFaller JM.
    Curr Eye Res; 1975 Aug; 2(2):141-7. PubMed ID: 6129113
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS.
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
    Mah FS, Rosenwasser LJ, Townsend WD, Greiner JV, Bensch G.
    Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.
    Berdy GJ, Spangler DL, Bensch G, Berdy SS, Brusatti RC.
    Clin Ther; 2000 Jul; 22(7):826-33. PubMed ID: 10945509
    [Abstract] [Full Text] [Related]

  • 8. Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis.
    Abelson MB, Paradis A, George MA, Smith LM, Maguire L, Burns R.
    Arch Ophthalmol; 1990 Apr; 108(4):520-4. PubMed ID: 2322153
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM, Tekelioglu Y, Turk A, Akyol N.
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Naphcon-A and its components (naphazoline and pheniramine) in a provocative model of allergic conjunctivitis.
    Dockhorn RJ, Duckett TG.
    Curr Eye Res; 1994 May; 13(5):319-24. PubMed ID: 8055694
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
    Leonardi A, Zafirakis P.
    Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519
    [Abstract] [Full Text] [Related]

  • 12. [Sodium cromoglycate eyewash in allergic conjunctivitis. Multicentric controlled double-blind study. Review of the literature].
    Bec P, Berard P, Bonnet M, Cazillas JM, Chagnon A, Ducourneau D, Fallas MC, Farnarier G, François P, Jourdan-Fonta D, Kastler M, Langle D, Mouillac-Gambarelli N, Morris D, Ourgaud AG, Pouliquen Y.
    J Fr Ophtalmol; 1982 Aug; 5(11):727-32. PubMed ID: 6818269
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of topical oxymetazoline in treating allergic and environmental conjunctivitis.
    Duzman E, Warman A, Warman R.
    Ann Ophthalmol; 1986 Jan; 18(1):28-31. PubMed ID: 3513687
    [Abstract] [Full Text] [Related]

  • 14. Understanding ocular comfort differences between 0.7% olopatadine and 0.3% pheniramine maleate/0.025% naphazoline hydrochloride eye drops.
    Lievens C, Pucker AD, McGwin G, Logan A, Franklin Q, Brafford R, Hogan C, Kelley LR, Christensen M.
    Clin Exp Optom; 2023 Jul; 106(5):498-502. PubMed ID: 35815690
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB, Greiner JV.
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [Abstract] [Full Text] [Related]

  • 16. Oxymetazoline ophthalmic solution versus naphazoline solution in non-infectious conjunctivitis.
    Rybiczka R, Mauracher E.
    Pharmatherapeutica; 1983 Dec; 3(6):376-81. PubMed ID: 6353428
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.
    Shulman DG, Lothringer LL, Rubin JM, Briggs RB, Howes J, Novack GD, Hart K.
    Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491
    [Abstract] [Full Text] [Related]

  • 18. Conjunctival temperature: a measure of ocular decongestant and anti-inflammatory activity.
    Salem H, Dunn BJ, Loux JJ.
    Ann Ophthalmol; 1975 Jun; 7(6):819-24. PubMed ID: 1147509
    [Abstract] [Full Text] [Related]

  • 19. [Prothanon eyedrops. 2. Results of clinical test in double-blind experiment].
    Bredemeyer I, Graupner K, Hammer R, Pambor R.
    Pharmazie; 1970 Feb 02; 25(2):118-20. PubMed ID: 4192879
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.
    Finegold I, Granet DB, D'Arienzo PA, Epstein AB.
    Clin Ther; 2006 Oct 02; 28(10):1630-8. PubMed ID: 17157118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.